
IJC Heart & Vasculature, Journal Year: 2024, Volume and Issue: 56, P. 101584 - 101584
Published: Dec. 21, 2024
Language: Английский
IJC Heart & Vasculature, Journal Year: 2024, Volume and Issue: 56, P. 101584 - 101584
Published: Dec. 21, 2024
Language: Английский
Cellular Signalling, Journal Year: 2025, Volume and Issue: 127, P. 111598 - 111598
Published: Jan. 7, 2025
Language: Английский
Citations
2Food Science and Biotechnology, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 27, 2025
Language: Английский
Citations
1APOPTOSIS, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 20, 2025
Language: Английский
Citations
0Published: Jan. 1, 2025
Language: Английский
Citations
0Free Radical Biology and Medicine, Journal Year: 2025, Volume and Issue: unknown
Published: April 1, 2025
Language: Английский
Citations
0Research Square (Research Square), Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 17, 2025
Language: Английский
Citations
0Anesthesiology and Perioperative Science, Journal Year: 2025, Volume and Issue: 3(1)
Published: Jan. 21, 2025
Abstract Pharmacological interventions with the inhaled anesthetic sevoflurane, widely used in cardiac surgery, have been reported to mimic cardioprotection produced by ischemic conditioning against myocardial ischemia–reperfusion injury. Beneficial effects of sevoflurane vary dose, time window and duration a variety studies involving both laboratory experiments clinical trials. However, are impaired or lost subjects diabetes settings mechanisms incompletely understood. This article summarizes major findings investigating sevoflurane-induced protection. Our aim is provide better understanding interrelated but poorly described signaling pathways. Moreover, this may facilitate development more effective therapeutic preventive strategies for ischemia-reperfusion
Language: Английский
Citations
0Circulation Reports, Journal Year: 2025, Volume and Issue: 7(3), P. 160 - 167
Published: Feb. 5, 2025
In the context of cardiovascular disease (CVD), iron metabolism assessment plays a pivotal role in diagnosis anemia and chronic inflammation. However, data regarding prevalence anemia, deficiency, overload among outpatients real-world clinical settings remain limited. Moreover, influence specific diseases on kinetics within CVD spectrum has not been fully elucidated. We conducted retrospective analysis 260 patients attending cardiology outpatient clinic who had undergone blood sampling for comprehensive evaluation kinetics. The these was 36.1%, but deficiency observed only 13.8% (absolute deficiency: 1.5%). Notably, stored positively correlated with free sinus rhythm, atrial fibrillation (AF). Intriguingly, this relationship followed similar pattern paroxysmal longstanding AF subgroups. multivariate regression showed that dynamics significantly explained hemoglobin levels rhythm those AF. Although inflammation may be contributing factor, exhibited distinct profile correlation between transferrin saturation iron, evident patients, abolished AF, which supports notion
Language: Английский
Citations
0Inflammation Research, Journal Year: 2025, Volume and Issue: 74(1)
Published: March 14, 2025
Language: Английский
Citations
0Frontiers in Pharmacology, Journal Year: 2025, Volume and Issue: 16
Published: March 18, 2025
Ferulic acid (FA) has shown potential in treating atherosclerosis (AS) by improving lipid metabolism and exerting anti-hypoxic effects. This study aimed to validate the mechanism of FA AS through vitro experiments. Network analysis was employed predict mechanisms underlying therapeutic effects on AS. An foam cell model established using RAW 264.7 cells treated with ox-LDL. Cellular accumulation detected Oil Red O staining; viability assessed counting kit-8; mitochondrial morphology function were evaluated transmission electron microscopy JC-1 apoptosis levels TUNEL DAPI Fe2+ content measured Mito-FerroGreen; Western blot performed determine protein expression HIF-1α, Bax, Bcl2, GPX4, EGFR. suggested that may exert its HIF-1 signaling pathway is closely associated regulation ferroptosis apoptosis. upregulated ALOX5, BCL2, ERN1, NOS3, SLC2A1 mRNA downregulated BAX, CYCS, EGFR, FLT1, HIF1A, NFKB1, NOS2, PARP1, STAT3 mRNA. In experiments demonstrated reduces accumulation, increases viability, improves function, decreases reactive oxygen species content. Additionally, inhibited suppressing pathway, up-regulating GPX4 down-regulating HIF-1α Bax protein. agonists reversed these activating pathway. suppresses inhibiting thereby
Language: Английский
Citations
0